Insights

Academic courses

  • Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation” (2015-2019)
  • Co-creator and lecturer for Patent Resources Group Advanced Patent Law Course, “Pharma & Biotech Strategies for Patent Prosecution, Hatch-Waxman, and Litigation” (2000-2014)

    • Additional insights

    Publications

  • “Patent-eligible Subject Matter in the Life Sciences in the United States,” Japanese IP Journal, Vol. 16 No. 1: 20-30 (2019)
  • “An End-Run Around Myriad And ‘Product Of Nature’ Problem,” Law360 (September 2016)
  • “Bulletproofing Pharma Patents,” LSIPR Newsletter (December 2014)
  • “Patenting Genes in a Post-Myriad World,” Industrial Biotechnology (August 2013)
  • “Myriad: Picking Up the Pieces,” LSIPR Newsletter (June 2013).
  • “Making Follow-On Biologics a Reality,” Genetic Engineering & Biotechnology News 31:8-10 (2011)
  • “U.S. Gene Patents in Legal Limbo—for Now,” Genetic Engineering & Biotechnology News 28:10 (2008)
  • “In Vitro HeLa DNA Synthesis: Investigation of the Nature of Replication and a Stimulatory Factor from HeLa Cells,” Ph.D. Thesis